EUVIMEDEUVIMED entdecken
Crossref

Comprehensive morphologic characterization of bone marrow biopsy findings in a large cohort of patients with VEXAS syndrome: A single-institution longitudinal study of 111 bone marrow samples from 52 patients

Horatiu Olteanu iD, Mrinal Patnaik, Matthew J Koster, Jennifer L Herrick, Dong Chen iD, Rong He iD, David Viswanatha, Kenneth J Warrington, Ronald S Go, Abhishek A Mangaonkar, Taxiarchis Kourelis, Alexander Hines iD und 3 weitere

American Journal of Clinical Pathology · 2024

DOI: 10.1093/ajcp/aqad186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2024. Verfasst von Horatiu Olteanu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematopathology, Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, US. Hauptthemen laut MEDLINE: Bone Marrow. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

VEXAS syndrome is an adult-onset autoinflammatory disease caused by a somatic pathogenic mutation in the UBA1 (ubiquitin-like modifier activating enzyme 1) gene. Patients present with rheumatologic manifestations and cytopenias and may have an increased predisposition to myelodysplastic syndrome (MDS) and plasma cell neoplasms. Prior studies have reported on the peripheral blood and bone marrow findings in patients with VEXAS syndrome. Due to the protean clinical presentation and lack of specificity of morphologic features (eg, vacuoles in early erythroid and granulocytic precursors), an optimal screening methodology to identify these patients in a timely fashion is desirable.

Methods

To further evaluate and describe the salient diagnostic morphologic features in VEXAS syndrome, we carried out a comprehensive study of the largest single-institution cohort to date. Diagnostic and follow-up bone marrow biopsy specimens from 52 male patients with molecularly identified VEXAS syndrome underwent central review.

Results

Cytopenias were common in all cases, primarily macrocytic anemia, monocytopenia, and thrombocytopenia. Bone marrow aspirate and biopsy were often hypercellular, with an increased myeloid/erythroid ratio, granulocytic hyperplasia with left shift, erythroid left shift, and megakaryocyte hyperplasia, which exhibited a range of striking morphologic findings. Distinctly vacuolated myeloid and erythroid precursors were seen in more than 95% of cases.

Conclusions

Our data reveal potential novel diagnostic features, such as a high incidence of monocytopenia and distinct patterns of atypical megakaryopoiesis, that appear different from dysmegakaryopoiesis typically associated with MDS. In our experience, those findings are suggestive of VEXAS, in the appropriate clinical context.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone MarrowHumansMaleMiddle AgedAdultAgedLongitudinal StudiesBiopsyUbiquitin-Activating EnzymesMyelodysplastic SyndromesYoung AdultAged, 80 and overCohort StudiesFemaleMutationThrombocytopenia

Stichwörter der Autor:innen

VEXAS syndromebone marrowhematopathologymorphology

Substanzen

UBA1 protein, humanUbiquitin-Activating Enzymes

Autor:innen und Institutionen

  • Division of Hematopathology, Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, US.
  • Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, US.
  • Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN, US.
  • Department of Dermatology, Mayo Clinic, Rochester, MN, US.
  • Division of Hematopathology, Department of Pathology and Laboratory Medicine, Mayo Clinic, Phoenix, AZ, US.

ORCID-Profile: Horatiu Olteanu, Dong Chen, Rong He, Alexander Hines, Sarah E Gibson

Zitieren

APA

Olteanu, H., Patnaik, M., Koster, M. J., Herrick, J. L., Chen, D., He, R., Viswanatha, D., Warrington, K. J., Go, R. S., Mangaonkar, A. A., Kourelis, T., Hines, A., Gibson, S. E., Peterson, J. F., & Reichard, K. K. (2024). Comprehensive morphologic characterization of bone marrow biopsy findings in a large cohort of patients with VEXAS syndrome: A single-institution longitudinal study of 111 bone marrow samples from 52 patients. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqad186

Vancouver

Olteanu H, Patnaik M, Koster MJ, Herrick JL, Chen D, He R, et al. Comprehensive morphologic characterization of bone marrow biopsy findings in a large cohort of patients with VEXAS syndrome: A single-institution longitudinal study of 111 bone marrow samples from 52 patients. American Journal of Clinical Pathology. 2024. doi:10.1093/ajcp/aqad186

BibTeX
@article{Olteanu2024,
  author = {Olteanu, Horatiu and Patnaik, Mrinal and Koster, Matthew J and Herrick, Jennifer L and Chen, Dong and He, Rong and Viswanatha, David and Warrington, Kenneth J and Go, Ronald S and Mangaonkar, Abhishek A and Kourelis, Taxiarchis and Hines, Alexander and Gibson, Sarah E and Peterson, Jess F and Reichard, Kaaren K},
  title = {Comprehensive morphologic characterization of bone marrow biopsy findings in a large cohort of patients with VEXAS syndrome: A single-institution longitudinal study of 111 bone marrow samples from 52 patients},
  journal = {American Journal of Clinical Pathology},
  year = {2024},
  doi = {10.1093/ajcp/aqad186}
}
Kostenlos starten →